Ubrogepant, erenumab, and eptinezumab antagonize positive inotropic effects of the calcitonin gene-related peptide in the isolated human atrium. - Neumann J; Hofmann B; Gergs U (Naunyn-Schmiedeberg's archives of pharmacology, 2025)